ADYNOVATE - Summary Basis of Decision (SBD) Antihemophilic Factor VIII (Recombinant), PEGylated https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00340 2016 false false false Canada French English drug evaluation factor VIII factor VIII recombinant proteins recombinant proteins drug approval canada hemorrhage hemorrhage intraoperative care hemophilia A polyethylene glycols treatment outcome summary of product characteristics coagulation factor VIII injections, intravenous BAX 855 BAX 855